Global Ovarian Cancer Market Size, Status and Forecast 2021-2027
- Published Date : 05-05-2021
- Pages : 91
- Report Id : 26897
- Categories : Healthcare
Ovarian cancer is a type of cancer that begins in the ovaries. Ovarian cancer is the most common type of cancer among women. Epithelial tumor, stromal tumor and germ cell tumors are the type of ovarian cancer.
North America dominates the global market for ovarian cancer due to large number of aging population. Asia is expected to show high growth rates in the next five years in the global ovarian cancer market. China and India are expected to be the fastest growing ovarian cancer markets in Asia-Pacific region. Some of the key driving forces for ovarian cancer market in emerging countries are rise in healthcare expenditure, large pool of patients and rising government funding.
In 2020, the global Ovarian Cancer market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% during 2021-2027.
This report focuses on the global Ovarian Cancer status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Ovarian Cancer development in United States, Europe and China.
The key players covered in this study
Bristol Myers Squibb
Eli Lilly
GlaxoSmithKline
Janssen Pharmaceuticals
Novogen
Genentech
Aetera Zenteris
Boehringer Ingelheim
Roche
Market segment by Type, the product can be split into
Surgery
Chemotherapy
Radiation
Biological Therapy
Market segment by Application, split into
Hospitals
Clinics
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Ovarian Cancer status, future forecast, growth opportunity, key market and key players.
To present the Ovarian Cancer development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Ovarian Cancer are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Ovarian Cancer Market Size Growth Rate by Type ( 2016-2027)
1.4.2 Surgery
1.4.3 Chemotherapy
1.4.4 Radiation
1.4.5 Biological Therapy
1.5 Market by Application
1.5.1 Global Ovarian Cancer Market Share by Application ( 2016-2027)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Ovarian Cancer Market Size
2.2 Ovarian Cancer Growth Trends by Regions
2.2.1 Ovarian Cancer Market Size by Regions ( 2016-2027)
2.2.2 Ovarian Cancer Market Share by Regions ( 2016-2021)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Ovarian Cancer Market Size by Manufacturers
3.1.1 Global Ovarian Cancer Revenue by Manufacturers ( 2016-2021)
3.1.2 Global Ovarian Cancer Revenue Market Share by Manufacturers ( 2016-2021)
3.1.3 Global Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
3.2 Ovarian Cancer Key Players Head office and Area Served
3.3 Key Players Ovarian Cancer Product/Solution/Service
3.4 Date of Enter into Ovarian Cancer Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Ovarian Cancer Market Size by Type ( 2016-2021)
4.2 Global Ovarian Cancer Market Size by Application ( 2016-2021)
5 United States
5.1 United States Ovarian Cancer Market Size ( 2016-2021)
5.2 Ovarian Cancer Key Players in United States
5.3 United States Ovarian Cancer Market Size by Type
5.4 United States Ovarian Cancer Market Size by Application
6 Europe
6.1 Europe Ovarian Cancer Market Size ( 2016-2021)
6.2 Ovarian Cancer Key Players in Europe
6.3 Europe Ovarian Cancer Market Size by Type
6.4 Europe Ovarian Cancer Market Size by Application
7 China
7.1 China Ovarian Cancer Market Size ( 2016-2021)
7.2 Ovarian Cancer Key Players in China
7.3 China Ovarian Cancer Market Size by Type
7.4 China Ovarian Cancer Market Size by Application
8 Japan
8.1 Japan Ovarian Cancer Market Size ( 2016-2021)
8.2 Ovarian Cancer Key Players in Japan
8.3 Japan Ovarian Cancer Market Size by Type
8.4 Japan Ovarian Cancer Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Ovarian Cancer Market Size ( 2016-2021)
9.2 Ovarian Cancer Key Players in Southeast Asia
9.3 Southeast Asia Ovarian Cancer Market Size by Type
9.4 Southeast Asia Ovarian Cancer Market Size by Application
10 India
10.1 India Ovarian Cancer Market Size ( 2016-2021)
10.2 Ovarian Cancer Key Players in India
10.3 India Ovarian Cancer Market Size by Type
10.4 India Ovarian Cancer Market Size by Application
11 Central & South America
11.1 Central & South America Ovarian Cancer Market Size ( 2016-2021)
11.2 Ovarian Cancer Key Players in Central & South America
11.3 Central & South America Ovarian Cancer Market Size by Type
11.4 Central & South America Ovarian Cancer Market Size by Application
12 International Players Profiles
12.1 Bristol Myers Squibb
12.1.1 Bristol Myers Squibb Company Details
12.1.2 Company Description and Business Overview
12.1.3 Ovarian Cancer Introduction
12.1.4 Bristol Myers Squibb Revenue in Ovarian Cancer Business ( 2016-2021)
12.1.5 Bristol Myers Squibb Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Ovarian Cancer Introduction
12.2.4 Eli Lilly Revenue in Ovarian Cancer Business ( 2016-2021)
12.2.5 Eli Lilly Recent Development
12.3 GlaxoSmithKline
12.3.1 GlaxoSmithKline Company Details
12.3.2 Company Description and Business Overview
12.3.3 Ovarian Cancer Introduction
12.3.4 GlaxoSmithKline Revenue in Ovarian Cancer Business ( 2016-2021)
12.3.5 GlaxoSmithKline Recent Development
12.4 Janssen Pharmaceuticals
12.4.1 Janssen Pharmaceuticals Company Details
12.4.2 Company Description and Business Overview
12.4.3 Ovarian Cancer Introduction
12.4.4 Janssen Pharmaceuticals Revenue in Ovarian Cancer Business ( 2016-2021)
12.4.5 Janssen Pharmaceuticals Recent Development
12.5 Novogen
12.5.1 Novogen Company Details
12.5.2 Company Description and Business Overview
12.5.3 Ovarian Cancer Introduction
12.5.4 Novogen Revenue in Ovarian Cancer Business ( 2016-2021)
12.5.5 Novogen Recent Development
12.6 Genentech
12.6.1 Genentech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Ovarian Cancer Introduction
12.6.4 Genentech Revenue in Ovarian Cancer Business ( 2016-2021)
12.6.5 Genentech Recent Development
12.7 Aetera Zenteris
12.7.1 Aetera Zenteris Company Details
12.7.2 Company Description and Business Overview
12.7.3 Ovarian Cancer Introduction
12.7.4 Aetera Zenteris Revenue in Ovarian Cancer Business ( 2016-2021)
12.7.5 Aetera Zenteris Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Company Details
12.8.2 Company Description and Business Overview
12.8.3 Ovarian Cancer Introduction
12.8.4 Boehringer Ingelheim Revenue in Ovarian Cancer Business ( 2016-2021)
12.8.5 Boehringer Ingelheim Recent Development
12.9 Roche
12.9.1 Roche Company Details
12.9.2 Company Description and Business Overview
12.9.3 Ovarian Cancer Introduction
12.9.4 Roche Revenue in Ovarian Cancer Business ( 2016-2021)
12.9.5 Roche Recent Development
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product ( 2021-2027)
13.10 Market Size Forecast by Application ( 2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
Table Ovarian Cancer Key Market Segments
Table Key Players Ovarian Cancer Covered
Table Global Ovarian Cancer Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Ovarian Cancer Market Size Market Share by Type 2016-2027
Figure Surgery Figures
Table Key Players of Surgery
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Radiation Figures
Table Key Players of Radiation
Figure Biological Therapy Figures
Table Key Players of Biological Therapy
Table Global Ovarian Cancer Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Ovarian Cancer Report Years Considered
Table Global Ovarian Cancer Market Size 2016-2027 (Million US$)
Figure Global Ovarian Cancer Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Ovarian Cancer Market Size by Regions 2016-2027 (Million US$)
Table Global Ovarian Cancer Market Size by Regions 2016-2021 (Million US$)
Table Global Ovarian Cancer Market Share by Regions 2016-2021
Figure Global Ovarian Cancer Market Share by Regions 2016-2021
Figure Global Ovarian Cancer Market Share by Regions 2021
Table Market Top Trends
Table Global Ovarian Cancer Revenue by Manufacturers ( 2016-2021) (Million US$)
Table Global Ovarian Cancer Market Share by Manufacturers ( 2016-2021)
Figure Global Ovarian Cancer Market Share by Manufacturers in 2020
Table Global Ovarian Cancer Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Ovarian Cancer Product/Solution/Service
Table Date of Enter into Ovarian Cancer Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table Global Ovarian Cancer Market Size Share by Type ( 2016-2021)
Figure Global Ovarian Cancer Market Size Market Share by Type ( 2016-2021)
Table Global Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table Global Ovarian Cancer Market Size Share by Application ( 2016-2021)
Figure Global Ovarian Cancer Market Size Market Share by Application ( 2016-2021)
Figure Global Ovarian Cancer Revenue Market Share by Application in 2020
Figure United States Ovarian Cancer Market Size 2016-2021 (Million US$)
Table United States Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table United States Key Players Ovarian Cancer Market Share ( 2020-2021)
Table United States Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table United States Ovarian Cancer Market Share by Type ( 2016-2021)
Table United States Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table United States Ovarian Cancer Market Share by Application ( 2016-2021)
Figure Europe Ovarian Cancer Market Size 2016-2021 (Million US$)
Table Europe Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table Europe Key Players Ovarian Cancer Market Share ( 2020-2021)
Table Europe Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table Europe Ovarian Cancer Market Share by Type ( 2016-2021)
Table Europe Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table Europe Ovarian Cancer Market Share by Application ( 2016-2021)
Figure China Ovarian Cancer Market Size 2016-2021 (Million US$)
Table China Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table China Key Players Ovarian Cancer Market Share ( 2020-2021)
Table China Ovarian Cancer Market Size by Type (2014- 20209) (Million US$)
Table China Ovarian Cancer Market Share by Type ( 2016-2021)
Table China Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table China Ovarian Cancer Market Share by Application ( 2016-2021)
Figure Japan Ovarian Cancer Market Size 2016-2021 (Million US$)
Table Japan Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table Japan Key Players Ovarian Cancer Market Share ( 2020-2021)
Table Japan Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table Japan Ovarian Cancer Market Share by Type ( 2016-2021)
Table Japan Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table Japan Ovarian Cancer Market Share by Application ( 2016-2021)
Figure Southeast Asia Ovarian Cancer Market Size 2016-2021 (Million US$)
Table Southeast Asia Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table Southeast Asia Key Players Ovarian Cancer Market Share ( 2020-2021)
Table Southeast Asia Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table Southeast Asia Ovarian Cancer Market Share by Type ( 2016-2021)
Table Southeast Asia Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table Southeast Asia Ovarian Cancer Market Share by Application ( 2016-2021)
Figure India Ovarian Cancer Market Size 2016-2021 (Million US$)
Table India Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table India Key Players Ovarian Cancer Market Share ( 2020-2021)
Table India Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table India Ovarian Cancer Market Share by Type ( 2016-2021)
Table India Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table India Ovarian Cancer Market Share by Application ( 2016-2021)
Figure Central & South America Ovarian Cancer Market Size 2016-2021 (Million US$)
Table Central & South America Key Players Ovarian Cancer Revenue ( 2020-2021) (Million US$)
Table Central & South America Key Players Ovarian Cancer Market Share ( 2020-2021)
Table Central & South America Ovarian Cancer Market Size by Type ( 2016-2021) (Million US$)
Table Central & South America Ovarian Cancer Market Share by Type ( 2016-2021)
Table Central & South America Ovarian Cancer Market Size by Application ( 2016-2021) (Million US$)
Table Central & South America Ovarian Cancer Market Share by Application ( 2016-2021)
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Ovarian Cancer Business ( 2016-2021) (Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Bristol Myers Squibb Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table GlaxoSmithKline Recent Development
Table Janssen Pharmaceuticals Company Details
Table Janssen Pharmaceuticals Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Janssen Pharmaceuticals Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Janssen Pharmaceuticals Recent Development
Table Novogen Company Details
Table Novogen Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Novogen Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Novogen Recent Development
Table Genentech Company Details
Table Genentech Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Genentech Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Genentech Recent Development
Table Aetera Zenteris Company Details
Table Aetera Zenteris Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Aetera Zenteris Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Aetera Zenteris Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Boehringer Ingelheim Recent Development
Table Roche Company Details
Table Roche Revenue in Ovarian Cancer Business ( 2016-2021)(Million US$)
Figure Roche Revenue Growth Rate in Ovarian Cancer Business ( 2016-2021)
Table Roche Recent Development
Table Global Ovarian Cancer Market Size by Regions (Million US$) 2021-2027
Figure Global Ovarian Cancer Market Size Share by Regions ( 2021-2027)
Figure Global Ovarian Cancer Market Size Share by Regions in 2027
Figure United States Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure Europe Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure China Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure Japan Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure Southeast Asia Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure India Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Figure Central & South America Ovarian Cancer Market Size Forecast ( 2021-2027)(Million USD)
Table Global Ovarian Cancer Market Size by Product ( 2021-2027) (Million US$)
Figure Global Ovarian Cancer Market Size by Product ( 2021-2027)
Figure Global Ovarian Cancer Market Size by Product in 2027
Table Global Ovarian Cancer Market Size by Application ( 2021-2027) (Million US$)
Figure Global Ovarian Cancer Market Size by Application ( 2021-2027)
Figure Global Ovarian Cancer Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Direct Purchase
Your perfect start with Research AlliedWant to customize this report?
This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Avail PDF Sample Reports
You may also be lnterested in..
Research Allied Copyright © 2024 .